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Introduction {#sec1}
============

The synapsin (Syn) family consists of three neuronal phosphoproteins encoded in mammals by distinct genes (i.e., SynI, II, and III). Although the biology of SynI and II has been extensively studied, the functions of SynIII are still largely uncharacterized. In vitro studies show that SynIII is involved in axonal elongation and growth-cone formation during early neurodevelopment ([@bib23; @bib24]). Accordingly, SynIII is the earliest expressed Syn isoform during development ([@bib41; @bib42]). Moreover, single-nucleotide polymorphisms in SynIII have been linked to neurodevelopmental disorders (i.e., schizophrenia; [@bib17]).

Similar to the other family members, SynIII is a substrate for protein kinases (PKs) ([@bib14]). Remarkably, many pathways that are essential for the migration and lamination of cortical neurons during brain development involve PKs and lead to the phosphorylation of specific substrates ([@bib2]). Thus, the developmental expression of SynIII, its role in neuronal developmental processes in vitro, and its phosphorylation profile suggest that it may be a downstream effector in neuronal migration.

Here, we showed that SynIII is involved in neocortical development in vivo; specifically, both the knockdown (KD) of SynIII and its genetic deletion lead to defective radial migration and orientation of layer II/III pyramidal neurons (PNs). Proper development requires SynIII phosphorylation by cyclin-dependent kinase-5 (CDK5), putting SynIII downstream of the semaphorin-3A (Sema3A)-signaling cascade.

Results {#sec2}
=======

SynIII Expression Is Required for Radial Migration of PNs In Vivo {#sec2.1}
-----------------------------------------------------------------

To investigate the role of SynIII in cortical development, we first confirmed its expression in the rat brain cortex at developmental stages ([Supplemental Results](#app2){ref-type="sec"}; [Figures S1](#app2){ref-type="sec"}A--S1F). Subsequently, we designed two short-hairpin (sh)RNAs against SynIII---but not SynI/II ([Figures S2](#app2){ref-type="sec"}A and S2B)---to examine the effects of SynIII KD on the radial migration of newly generated cortical PNs in vivo. Using in utero electroporation (IUE) at embryonic day 17 (E17), we expressed active shRNAs (shRNA no. 1 and shRNA no. 2) or a control scrambled shRNA vector (shRNAscr; [Figures S2](#app2){ref-type="sec"}A and S2B) in a subpopulation of neural progenitors that would normally migrate to layer II/III of the somatosensory cortex ([@bib19]). We analyzed the radial migration of layer II/III PNs derived from shRNA^+^ progenitors at E21 and postnatal day 7 (P7) (the first and last time points during the peak of SynIII expression, respectively) as well as at P14 (the first time point at which SynIII expression begins to be endogenously downregulated; see [Figures S1](#app2){ref-type="sec"}A and S1B).

At E21, control shRNAscr^+^ cells were primarily found in the cortical plate (CP) and intermediate zone (IZ), whereas only few cells remained in the ventricular zone/subventricular zone (VZ/SVZ) ([Figures 1](#fig1){ref-type="fig"}A and 1B). The migrating PNs located at the IZ expressed SynIII at E21 ([Figures S1](#app2){ref-type="sec"}G and S1H). Interestingly, we observed a significant delay in radial migration when either shRNA no. 1 or no. 2 was electroporated ([Figures 1](#fig1){ref-type="fig"}A and 1B). As the effect on migration was larger in shRNA no. 1 experiments, we performed all subsequent experiments with this construct (shRNA onward).

At P7, almost all shRNAscr^+^ cells reached cortical layer II/III, whereas many shRNA^+^ cells were misplaced in deep layers ([Figures 1](#fig1){ref-type="fig"}C and 1I). We defined these cells as "ectopic" PNs ([Figure 1](#fig1){ref-type="fig"}H). The severity of misplacement was proportional to the severity of SynIII downregulation ([Supplemental Results](#app2){ref-type="sec"}; [Figure S2](#app2){ref-type="sec"}E). To investigate whether the effect of SynIII KD was long lasting, we examined neuronal migration at P14, when endogenous expression of SynIII is low (see [Figures S1](#app2){ref-type="sec"}A and S1B). We found that SynIII shRNA^+^ cortices exhibited ectopic cells at P7 ([Figures 1](#fig1){ref-type="fig"}C, 1H, and 1I) and at P14 ([Figures S3](#app2){ref-type="sec"}D and S3E). SynIII downregulation did not affect neuronal identity, proliferation, or radial glia (RG) scaffold organization ([Supplemental Results](#app2){ref-type="sec"}; [Figures S2](#app2){ref-type="sec"}C, S2D, and S2F).

SynIII Regulates the Orientation of PNs In Vivo {#sec2.2}
-----------------------------------------------

Cell migration, orientation, and polarization share molecular mechanisms, and often the same proteins are involved in all three processes ([@bib16; @bib39; @bib50]). To further explore the role of SynIII in cortical development in vivo, we investigated whether its KD affected the orientation of PNs in the layer II/III. Control cells were typically characterized by an upright (UR) orientation with a pyramid-shaped cell body, one thick apical dendrite directed toward the pial surface, and one axon pointing to the ventricle. Interestingly, ∼20% of SynIII shRNA^+^ PNs were misoriented in layer II/III ([Figure 1](#fig1){ref-type="fig"}D; [@bib39]), ∼10% of PNs were inverted (IN), and ∼10% of PNs were horizontal (HOR) ([Figures 1](#fig1){ref-type="fig"}F and 1G). Similar results were obtained at P14 ([Figures S3](#app2){ref-type="sec"}A--S3C).

Given the common mechanisms involved in migration and orientation ([@bib16]), we expected a larger effect on the orientation of ectopic cells. Indeed, ∼1/3 of ectopic cells depleted of SynIII were IN ([Figures 1](#fig1){ref-type="fig"}E and 1H--1J). When we divided the cortical region where the ectopic cells were located (from layer IV to layer VI) in two equal parts, we found that, whereas ∼65% of the ectopic cells were located in the upper half, the IN ectopic cells were evenly distributed in the two halves, suggesting that the cortical location and neuronal orientation were not causally linked ([Figure 1](#fig1){ref-type="fig"}K). Moreover, when we immunostained against the γ-tubulin centrosomal marker, we found that the centrosome colocalized with the apical dendrite regardless of cell orientation in both shRNAscr^+^ and SynIII shRNA^+^ cells ([Figure S4](#app2){ref-type="sec"}A). Whereas SynIII regulated the morphological maturation of PNs both in the axonal and dendritic compartments, it did not affect the basic electrophysiological proprieties of PNs ([Supplemental Results](#app2){ref-type="sec"}; [Figures S3](#app2){ref-type="sec"}F--S3L and S4C--S4E).

Finally, we investigated whether SynIII KD also affected the orientation and migration of PNs in deep cortical layers (i.e., IV/V) by performing IUE at earlier embryonic stages (E15.5). In P7 SynIII shRNA-transfected brains, we found migration defects and significant cell misorientation similar to that observed in superficial layers ([Figure S4](#app2){ref-type="sec"}B).

The Co-expression of shRNA-Resistant SynIII Rescues the Defects Associated with Endogenous SynIII KD {#sec2.3}
----------------------------------------------------------------------------------------------------

To exclude off-target effects ([@bib20]), we generated a shRNA-resistant SynIII cDNA with four silent mutations in the shRNA target sequence (rSynIII; [Figure 2](#fig2){ref-type="fig"}A). After confirming rSynIII insensitivity to shRNA ([Figure 2](#fig2){ref-type="fig"}B), we performed rescue experiments with rSynIII/shRNA co-expression in E17 embryos. The co-expression of rSynIII and shRNA at a ratio of 0.5:1 rescued the delay in radial migration at E21 ([Figures 2](#fig2){ref-type="fig"}C and 2D) as well as the number and orientation of ectopic cells ([Figures 2](#fig2){ref-type="fig"}E--2G); however, the phenotype of HOR and IN cells in the CP at P7 was not rescued ([Figures 2](#fig2){ref-type="fig"}H and 2I). It is possible that the lack of rescue in the orientation phenotype in the CP was due to the concentration gradient of SynIII expression across the cortex, which shows the highest levels in the CP ([Figures S1](#app2){ref-type="sec"}C and S1F). Indeed, by increasing the SynIII/shRNA ratio to 1:1, we achieved complete rescue of the orientation defect of layer II/III PNs ([Figures 2](#fig2){ref-type="fig"}H and 2I).

SynIII KO Mice Display a Cortical Phenotype Similar to SynIII shRNA-Electroporated Animals {#sec2.4}
------------------------------------------------------------------------------------------

Although SynIII knockout (KO) mice display behavioral defects and changes in synaptic transmission, no gross brain abnormalities have been described ([@bib23; @bib43]). Nevertheless, no study has specifically investigated whether subtler developmental defects occur in the SynIII KO somatosensory cortex.

To address this issue, we first performed immunostaining with layer-specific markers (i.e., CUX1, layer II/III/IV; CTIP2, layer V; FOXP2, layer VI) in somatosensory cortex slices of SynIII KO and control littermates. We did not observe any overt abnormality in cortical layering at P7 in SynIII KO mice ([Figure S5](#app2){ref-type="sec"}). Thus, we considered two possible scenarios: (1) given the high homology among Syn isoforms, other members of the family, such as SynI, which is also expressed at embryonic ages, may compensate for SynIII's absence during development and (2) immunostaining with layer-specific markers may not be sufficiently sensitive to detect mild migration/orientation defects.

To investigate possibility (1), we performed co-electroporation of SynI with SynIII shRNA and assessed the migration/orientation defect in P7 mouse slices. We found that SynI could not rescue SynIII shRNA effects, indicating that SynI cannot compensate for loss of SynIII-specific functions during development ([Figures 3](#fig3){ref-type="fig"}A--3D). To investigate possibility (2), we performed IUE with a pCAGGs-IRES-tdTomato (Tom) vector to visualize migrating PNs in E15.5 SynIII KO and wild-type (WT) mice. In agreement with the cortical phenotype of shRNA-electroporated animals, we observed a misorientation of an ∼20% of PNs at the level of the CP in all KO brains ([Figures 3](#fig3){ref-type="fig"}E--3G). Interestingly, in contrast to controls, in two out of seven KO animals analyzed, we observed PNs in ectopic positions, with these cells occasionally exhibiting IN orientation ([Figures 3](#fig3){ref-type="fig"}E and 3H).

The Overexpression of SynIII Affects Radial Migration of PNs In Vivo {#sec2.5}
--------------------------------------------------------------------

While rescuing orientation defects in the CP ([Figures 2](#fig2){ref-type="fig"}H and 2I), the co-transfection of shRNA rSynIII and shRNA at a ratio 1:1 also led to ectopic cells in deep cortical layers ([Figures S6](#app2){ref-type="sec"}A and S6B); however, these cells did not exhibit orientation defects ([Figure S6](#app2){ref-type="sec"}C). Given the tight temporal regulation of SynIII expression, we hypothesized that not only downregulation/deletion but also overexpression of SynIII could interfere with proper radial migration of PNs. To test this hypothesis, we overexpressed WT SynIII by IUE at E17. At E21, PNs expressing either Tom or SynIII properly migrated through the cortex toward the CP ([Figures 4](#fig4){ref-type="fig"}A and 4B). Nonetheless, a significant percentage of SynIII-overexpressing cells were misplaced at P7 ([Figures 4](#fig4){ref-type="fig"}C and 4F--4H). The effect of SynIII on neuronal migration was long-lasting, as SynIII overexpression also caused the appearance of ectopic cells at P14 ([Figures S6](#app2){ref-type="sec"}G and S6H).

Thus, SynIII overexpression, KD, and KO all affected migration and resulted in the ectopic placement of cells. However, SynIII-overexpressing cells were all properly oriented ([Figures 4](#fig4){ref-type="fig"}C--4H and [S6](#app2){ref-type="sec"}D--S6H). These effects could be due to subcellular mislocalization of SynIII upon overexpression in vivo, as we demonstrated in neuronal cultures ([Figure S6](#app2){ref-type="sec"}I).

SynIII Is Phosphorylated by CDK5 at Ser^404^ Both In Vitro and In Vivo {#sec2.6}
----------------------------------------------------------------------

Similar to the phenotype found for SynIII KD during development, CDK5 KO leads to a delay in radial migration and misoriented PNs ([@bib36]).

By analyzing the amino acid sequence of SynIII, we observed that it carries a conserved consensus sequence for CDK5 phosphorylation, with Ser^404^ predicted to be the target ([@bib52]). Moreover, we found that CDK5 was expressed in rat cortices during development as early as E15 ([Figures 5](#fig5){ref-type="fig"}A and 5B) and that CDK5 and SynIII expression are highly correlated at perinatal ages ([Figure 5](#fig5){ref-type="fig"}C). Interestingly, we found that SynIII and CDK5 co-immunoprecipitated from lysates of rat primary cortical neurons grown for 4 days in vitro (DIV) ([Figure 5](#fig5){ref-type="fig"}D), demonstrating that SynIII and CDK5 physically interact. SynIII and the neuron-specific CDK5 activator p35 consistently colocalized in developing neurons in vitro ([Figure 5](#fig5){ref-type="fig"}E).

To test whether SynIII is indeed phosphorylated by CDK5, we performed an in vitro phosphorylation assay ([Figures 5](#fig5){ref-type="fig"}F--5H). We first generated a non-phosphorylatable SynIII mutant in which Ser^404^ was replaced with an Ala. When immunoprecipitated and dephosphorylated SynIII or its S404A mutant was phosphorylated in vitro by active p35/CDK5 complex ([Figure 5](#fig5){ref-type="fig"}G), we observed that SynIII was phosphorylated by CDK5, whereas phosphorylation was significantly decreased by ∼31% in the S404A SynIII mutant ([Figures 5](#fig5){ref-type="fig"}G and 5H). This result indicates that Ser^404^ represents almost 1/3 of the total CDK5-mediated SynIII phosphorylation.

To test whether CDK5 phosphorylates SynIII in vivo, we performed liquid chromatography tandem mass spectrometry (LC-MS/MS) on endogenous SynIII from rat brains at P1, the peak of SynIII expression. In [Figure 5](#fig5){ref-type="fig"}I, the predicted m/z values of fragment ions are shown in blue or red, indicating identified b- and y-type ions, respectively. This experiment confirmed the presence of Ser^404^ phosphorylation in vivo.

Finally, we generated a phosphorylation-state-specific antibody recognizing phospho-Ser^404^ in SynIII. After testing its specificity for phospho-Ser^404^ ([Figure S7](#app2){ref-type="sec"}B), we analyzed the phosphorylation of SynIII on Ser^404^ in vivo. We found that the absolute amount of phosphorylated SynIII present in the cortex plateaued at P1--P7 and then dropped to undetectable levels at P16--P35. However, the fraction of phospho-SynIII to total SynIII was high at very early stages of development (E15--E18) and steadily decreased thereafter to become undetectable at P16 ([Figures 5](#fig5){ref-type="fig"}J and 5K).

SynIII Phosphorylation at CDK5 Site Regulates SynIII Effects {#sec2.7}
------------------------------------------------------------

To test whether SynIII is indeed a downstream effector of CDK5 during development in vivo, we generated a pseudo-phosphorylated SynIII mutant by replacing Ser^404^ with an Asp (D), which mimics the negative charge of the phosphate group (rSynIII S404D). We next verified that both S404A and S404D rSynIII expression and subcellular distribution were similar to that of the WT protein ([Figures S7](#app2){ref-type="sec"}C--S7E).

When expressed alone, rSynIII S404A caused a delay in radial migration at E21 similar to that observed in the SynIII KD experiments ([Figures 6](#fig6){ref-type="fig"}A and 6B), indicating that this mutant may act in a dominant-negative manner on endogenous SynIII. Interestingly, when overexpressed at P7, rSynIII S404A resulted in the appearance of ectopic cells without orientation defects ([Figures 6](#fig6){ref-type="fig"}C, 6E, and 6F), suggesting that the presence of the endogenous SynIII is sufficient to guarantee proper neuronal orientation. Consistent with the dominant-negative effect of the mutant on migration, when S404A rSynIII was co-expressed with shRNA at a 0.5:1 or 1:1 ratio (as was done for WT rSynIII; [Figures 2](#fig2){ref-type="fig"}H and 2I), it did not rescue the shRNA-induced migration defects at either E21 ([Figures 6](#fig6){ref-type="fig"}A and 6B) or P7 ([Figures 6](#fig6){ref-type="fig"}C and 6E). Moreover, the co-transfection of S404A rSynIII with shRNA at either ratio did not rescue the orientation defects in PNs located in the CP ([Figure 6](#fig6){ref-type="fig"}D) or in ectopic PNs ([Figure 6](#fig6){ref-type="fig"}F). Conversely, when co-electroporated with shRNA at a 0.5:1 ratio, S404D rSynIII significantly rescued the delay in radial migration caused by SynIII KD at E21 ([Figures S7](#app2){ref-type="sec"}F and S7G).

SynIII Is Downstream of Sema3A-Signaling Cascade {#sec2.8}
------------------------------------------------

CDK5 is a downstream effector in the Sema3A pathway, and alterations in this pathway at various levels all cause a phenotype similar to SynIII KD in the cortex ([@bib39; @bib6]). To test the possibility that SynIII acts downstream of the Sema3A-signaling cascade, we investigated SynIII phosphorylation by CDK5 in 4-DIV cortical neurons after stimulation with 1 nM Sema3A. We observed that SynIII was phosphorylated on Ser^404^ only 5 min after the stimulus, and its phosphorylation significantly increased after 20 and 30 min in comparison to vehicle-treated cells ([Figures 7](#fig7){ref-type="fig"}A and 7B).

We next tested the causal involvement of SynIII in the Sema3A pathway in vivo. First, we investigated the expression of the Sema3A receptor neuropilin 1 (NP1) ([@bib16]) in rat brain cortices. NP1 expression was highly similar to that of SynIII during development, with a maximum expression between E21 and P7, followed by a sharp decrease immediately thereafter ([Figures 7](#fig7){ref-type="fig"}C--7E). Moreover, as was seen for p35, we observed a colocalization of SynIII and NP1 in developing neurons in vitro ([Figure 7](#fig7){ref-type="fig"}F), suggesting that these three molecules may indeed be part of the same signaling cascade.

Next, to investigate the Sema3A/CDK5/SynIII pathway in vivo, we electroporated a shRNA against NP1 in rat embryos ([@bib16]). As expected ([@bib16]), we observed a very strong effect on the radial migration of layer II/III PNs at P7, with only ∼35% of PNs reaching the CP ([Figures 7](#fig7){ref-type="fig"}G and 7H). However, when we co-expressed S404D rSynIII and NP1 shRNA, we significantly rescued radial migration ([Figures 7](#fig7){ref-type="fig"}G and 7H), with ∼50% more PNs reaching the CP in comparison to NP1 shRNA-electroporated brains.

Discussion {#sec3}
==========

During cortical development, post-mitotic PNs migrate away from the VZ along RG fibers toward the surface of the CP. On reaching the superficial layer, PNs stop migrating, detach from RG fibers, and morphologically differentiate.

In this study, we showed that SynIII, the Syn isoform that is most precociously expressed, plays a key role in cortical development. KD, KO, or upregulation of SynIII caused defects in radial migration, with the appearance of ectopic cells at later stages. Moreover, SynIII KD/KO caused significant orientation defects in ectopic PNs as well as in PNs that fully completed their radial migration. Interestingly, in misoriented PNs, the centrosome was properly located on the side of the apical dendrite. If centrosome localization ahead of the nucleus in the direction of migration is necessary for neuronal migration ([@bib51]), the question arises of how most of the SynIII-KD-misoriented neurons completed their migration. It is possible that SynIII-KD neurons migrate along glial fibers when the leading process is directed to the pial surface and stop migrating when they change orientation. Conceivably, re-orientation of migrating PNs occurs several times during migration, and---consistent with the higher levels of SynIII shRNA in ectopic PNs---the more SynIII is KD, the more migrating cells will re-orientate, resulting in a slower migration and ultimate ectopic positioning. Conversely, PNs expressing lower levels of SynIII shRNA will reach the CP, detach from RG fibers, and, without the fiber's restriction, acquire all possible degrees of orientation before morphological maturation. SynIII KD causes the described phenotypes through a cell-autonomous mechanism, as confirmed by an intact RG scaffold in shRNA-transfected brains.

The migration and orientation defects involved the Sema3A-signaling cascade; indeed, upon Sema3A stimulation, SynIII is phosphorylated by CDK5. As shown by SynIII phospho mutant experiments, this phosphorylation is essential for SynIII activity. Thus, we propose a unifying model in which SynIII acts downstream Sema3A/CDK5 signaling to control neuronal migration and orientation ([Figure 7](#fig7){ref-type="fig"}I). Given that SynIII KD caused similar defects when performed in neuronal progenitors of both layer II/III and layer IV/V, and considering that CDK5 activity is essential for migration and dendrite development of layer V PNs ([@bib36]), we hypothesize that the mechanism by which SynIII regulates proper cortical organization is generalizable to the development of all cortical layers. Future studies should investigate whether SynIII also regulates migration in other brain areas, as previously described for CDK5 ([@bib30]).

Tight Spatial and Temporal Regulation of SynIII Controls Neuronal Migration and Orientation during Development {#sec3.1}
--------------------------------------------------------------------------------------------------------------

Although many factors have been identified in recent years to be involved in cortical migration, we are still far from understanding the entire framework, and many actors await identification. Among these, SynIII was a good candidate. First, the emergence of the *Syn3* gene correlates with the appearance of the telencephalic region during evolution ([@bib32]). Second, we demonstrated that SynIII is highly expressed and phosphorylated on Ser^404^ during development and has a well-defined spatial expression along cortical layers at distinct developmental stages. Finally, in vitro data suggest a role for SynIII in neuronal development ([@bib24]).

Here, we showed that SynIII modulates neuronal migration and orientation in vivo. In particular, a tight regulation of SynIII expression is necessary for proper cortical development. Indeed, SynIII expression peaks in a defined temporal window, beyond which it is detrimental for cortical PN development, as proven by the following facts: (1) both SynIII KD and overexpression caused defects in radial migration and in the morphological maturation of PNs; (2) a shRNA-insensitive rSynIII completely rescued the KD phenotypes only when co-expressed with shRNA at optimal levels; and (3) the cortical phenotype caused by SynIII KD during early development was irreversible and persisted even when the expression of the protein was endogenously downregulated at later developmental stages, such as P14 (also see the [Supplemental Discussion](#app2){ref-type="sec"}).

SynIII KO and SynIII shRNA-Transfected Brains Share Common Features {#sec3.2}
-------------------------------------------------------------------

Data from the literature indicated no major brain abnormalities in SynIII KO mice ([@bib23]), whereas our data demonstrated that acute KD of SynIII by RNAi profoundly affected cortical development. Interestingly, many other cases have been described where acute KD of a specific protein in a subset of neurons by IUE leads to strong defects in brain development, whereas the constitutive KO of the same protein does not lead to an apparent phenotype (e.g., DCX, [@bib18] versus [@bib3]; p75, [@bib34] versus [@bib55]; GABA~B~ receptor, [@bib49] versus [@bib11]). Two main reasons could explain this finding: (1) the chronic and widespread depletion of the protein in KO mice could trigger redundancy or compensatory mechanisms by other proteins that overcome the deficits in brain development and/or (2) subtle developmental impairments in KO animals may be simply overlooked due to the complexity of the in vivo system and/or the lack of adequate methods to study mild defects. Here, we provided evidence for both possibilities. Indeed, marking developing neurons with a fluorescent reporter via IUE in SynIII KO mice allowed us to examine their cortical development with an unprecedented focus on neuronal migration and orientation. Using this technique allowed us to conclude that SynIII KO animals display the same phenotype as observed in shRNA-transfected brains, although to a milder extent.

Because of the high homology between SynIII and SynI/II, we hypothesized that they could compensate for the loss of SynIII and that this compensation could result in a mild developmental phenotype in KO animals. Nevertheless, we showed that SynII is not significantly expressed at perinatal ages in the cortex and that the overexpression of SynI did not rescue SynIII shRNA-mediated effects. It is possible that the differences between SynI and SynIII in terms of their amino acid sequence, location of phosphorylation sites, and spatio-temporal expression profile could account for their lack of involvement in neuronal migration and orientation.

In conclusion, we hypothesize that proteins other than SynI and II may compensate for SynIII loss in KO animals, and we propose the use of IUE for expressing fluorescent reporters as a means to uncover subtle developmental phenotypes in KO animals.

SynIII Is Part of the Sema3A Pathway {#sec3.3}
------------------------------------

Our data consistently show that SynIII KD leads to a peculiar effect in the orientation of neurons located in the CP and also in the ectopic cells. Interestingly, the orientation defects in cortical neurons described in the literature are primarily associated with the faulty expression of genes involved in the Sema3A-signaling pathway ([@bib6; @bib15; @bib16; @bib36; @bib38; @bib39; @bib48; @bib50]). Sema3A is a secreted protein well known for its role as a guidance signal upon binding to its receptor NP1. NP1 associates with its co-receptor plexin A2 to activate Fyn kinase. Then, Fyn activation promotes CDK5 binding to plexin A2 and eventually activates CDK5 by phosphorylating it on Tyr^15^ ([Figure 7](#fig7){ref-type="fig"}I).

SynIII carries a highly conserved putative site for CDK5 phosphorylation (Ser^404^). We demonstrated that SynIII physically interacts with CDK5 and is a substrate for the kinase by showing that (1) SynIII and CDK5 are both expressed at perinatal ages in the cortex and colocalize in developing neurons in culture; (2) SynIII and CDK5 co-immunoprecipitate; and (3) SynIII is phosphorylated by CDK5 both in vitro and in vivo.

The rescue experiments performed with phospho mutants in vivo proved that Ser^404^ phosphorylation has a biological significance and that the phenotype we observed in SynIII-null PNs is at least partially due to a missing step in CDK5 signaling. Moreover, we showed that Ser^404^ phosphorylation increased upon Sema3A stimulation in vitro and that the pseudo-phosphorylated mutant S404D rSynIII partially compensated for the loss of Sema3A signaling caused by NP1 KD in vivo. Thus, our data demonstrate that SynIII is part of the Sema3A pathway ([Figure 7](#fig7){ref-type="fig"}I; also see the [Supplemental Discussion](#app2){ref-type="sec"}).

Hypothetical Mechanisms of Action of SynIII {#sec3.4}
-------------------------------------------

How could SynIII translate Sema3A signaling into inputs for neuronal migration and orientation? Little is known regarding SynIII interactors. In general, Syn family members can bind to synaptic vesicles (SVs), actin ([@bib8; @bib9; @bib10]), and tubulin ([@bib37]) through the highly conserved A, C, and E domains ([@bib13; @bib32]). These domains are also present in SynIII. Indeed, SynIII also binds SVs and regulates their trafficking within nerve terminals ([@bib31]). As the regulation of cytoskeletal dynamics and SV trafficking are requisites for membrane rearrangements during cell migration ([@bib29]), SynIII may participate in radial migration by the latter processes ([Figure 7](#fig7){ref-type="fig"}I). The phenotypic features of SynIII-KD or -overexpressing PNs support this hypothesis: delayed migration, ectopic positioning, and morphologically impaired leading processes are typical of neurons that lose their contact with RG fibers ([@bib22; @bib27; @bib47; @bib53]). The dysregulation of SynIII activity could indeed interfere with the cytoskeletal dynamics and membrane rearrangements involved in the formation and disassembly of cell adhesions and, consequently, interactions between migrating neurons and RG fibers ([@bib45]; also see the [Supplemental Discussion](#app2){ref-type="sec"}).

Concluding Remarks {#sec3.5}
------------------

In this study, we showed that SynIII acts downstream Sema3A and regulates the radial migration and orientation of PNs. Neuronal migration is fundamental for the development of a fully functional brain, as demonstrated by the implication of defective neuronal migration in a number of neurodevelopmental disorders ([@bib2]). Interestingly, experimental evidence implies the Sema3A/SynIII pathway in schizophrenia. Indeed, Sema3A-signaling dysregulation in brains from individuals with schizophrenia ([@bib21]) and a genetic linkage between SynIII mutations and schizophrenia have been reported ([@bib28; @bib33; @bib42]). Moreover, as we observed in SynIII KD/KO animal model brains, reduced SynIII expression ([@bib40]), abnormal cytoarchitecture, and dendritic aberrations ([@bib1; @bib7; @bib26; @bib35; @bib44; @bib46]) have also been reported in the brains of individuals with schizophrenia. Interestingly, the altered directionality of axonal elongation in SynIII-KD neurons that we describe in the present study is consistent with the disruption of axonal fiber connectivity in schizophrenic patients ([@bib54]). Finally, SynIII KO mice exhibit abnormal sensory motor gating in response to prepulse inhibition ([@bib25]), similar to what is observed in patients with schizophrenia and in mouse models of schizophrenia.

Thus, the clarification of the role of SynIII in the Sema3A pathway could be important in shedding light on the pathogenesis of neurodevelopmental diseases and further increase our knowledge of the complex mechanisms that regulate cortical development in health and disease.

Experimental Procedures {#sec4}
=======================

Generation of Constructs {#sec4.1}
------------------------

For detailed cloning procedures and list of used primers, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Cell Cultures, Transfection, and Stimulation {#sec4.2}
--------------------------------------------

### COS7 Cell Culture and Transfection {#sec4.2.1}

COS7 cells were cultured in Dulbecco's MEM (DMEM) (GIBCO) supplemented with 10% fetal calf serum (GIBCO), 1% L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (Biowhittaker) and maintained at 37°C in a 5% CO~2~ humidified atmosphere. The cells were transfected with Fugene 6 (Roche). For detailed procedures, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

### Cortical Neuron Culture and Neuronal Stimulation {#sec4.2.2}

Primary cultures of dissociated cortical neurons were prepared from E18 rats and maintained in Neurobasal medium supplemented with 2% B-27, 0.5 mM glutamine, 50 U/ml penicillin, and 50 μg/ml streptomycin (Invitrogen). The neurons were maintained at 37°C in a 5% CO~2~ humidified atmosphere. For stimulation experiments, the neurons were washed with Neurobasal medium and incubated for 30 min at 37°C. mSema3A-Fc (1 nM; R&D Systems) was added to the medium and, after incubation, the cells were lysed and processed for western blot.

Western Blotting {#sec4.3}
----------------

Total cell lysates were obtained from COS7 cells 48 hr after transfection or from cortical neuron cultures at 4 DIV. For detailed procedures, reagents, and a list of antibodies, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Immunoprecipitation and In Vitro Protein Dephosphorylation/Phosphorylation Assays {#sec4.4}
---------------------------------------------------------------------------------

Following transient transfection, COS7 cells were lysed and SynIII and S404 SynIII were immunoprecipitated and dephosphorylated. The samples were then subjected to in vitro phosphorylation. For detailed procedures and reagents, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Animals and IUE {#sec4.5}
---------------

Sprague-Dawley rats and C57BL/6J mice were from Charles River Laboratories or Harlan. SynIII KO mice were generated by homologous recombination ([@bib23]) and backcrossed onto the C57BL/6J background for over ten generations. All of the experiments were performed in accordance with the guidelines established by the European Communities Council (Directive 2010/63/EU of September 22nd, 2010) and were approved by the Italian Ministry of Health.

Standard IUE was performed as previously described ([@bib19]). For detailed procedures and reagents, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Slice Histology and Immunostaining {#sec4.6}
----------------------------------

Slice histology and immunostaining were performed as previously described ([@bib11]). For detailed procedures, antibodies, and reagents, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Images Acquisition and Analysis {#sec4.7}
-------------------------------

The images were acquired using a confocal laser-scanning microscope (TCS SP5; Leica Microsystems) or with an epifluorescence microscope equipped with Neurolucida (MicroBrightField) software. For detailed procedures on acquisition and analysis, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Mass Spectrometry {#sec4.8}
-----------------

Endogenous SynIII was immunoprecipitated from P1 brains. For detailed procedures, see the [Supplemental Experimental Procedures](#app2){ref-type="sec"}. Immunoprecipitated SynIII was then processed for mass spectrometry analysis. In-gel tryptic digests were performed as previously described ([@bib4]), and extracted peptides were subjected to LC-MS/MS analysis in a linear ion trap-orbitrap mass spectrometer, as previously described ([@bib5; @bib12]) and detailed in [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Statistics {#sec4.9}
----------

If not indicated otherwise in the legend, the numbers in parentheses on the histograms indicate the number of processed animals. One slice per animal was analyzed. Statistical analysis between control and experimental groups was performed with Student's t test or, in the case of more than two experimental groups, with one-way ANOVA followed by post hoc multiple comparisons. For non-normally distributed data, ANOVA on ranks test and non-parametric post hoc comparisons were used. Outliers were excluded with the Grubb's test. We used GraphPad (GraphPad Software) and SigmaStat (Systat Software) software. All of the data are presented as the means ± SEM.
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![SynIII KD Affects Radial Migration and Neuronal Orientation In Vivo\
(A) Confocal images of rat somatosensory cortices at E21 after IUE at E17 with control scrambled shRNA (shRNAscr, control) or SynIII shRNA no. 1. The scale bar represents 100 μm.\
(B) Quantification of the average number of PNs transfected with shRNAscr (control), shRNA no. 1, or shRNA no. 2 and residing at the VZ/SVZ, IZ, or CP (marked in A). The data are mean percentages (±SEM) of the total number of fluorescent cells (one-way ANOVA; post hoc Holm-Sidak: ^∗∗∗^p \< 0.001).\
(C) Confocal images of rat somatosensory cortices at P7 after IUE at E17 with control scrambled shRNA (shRNAscr, control) or SynIII shRNA no. 1. Arrowheads: sample neurons that did not complete radial migration at P7 (black, UP neurons; gray, IN neurons). The scale bar represents 50 μm.\
(D) Schematics of apical dendrite orientation used for classification in (E)--(G). HOR, horizontal orientation; IN, inverted orientation; UR, upright orientation.\
(E) High-magnification image of the boxed region in (C). The scale bar represents 50 μm.\
(F) Reconstruction of representative control and shRNA^+^ cells in the CP. The scale bar represents 50 μm.\
(G) Quantification of the distribution of CP cells in the three distinct classes, as in (D) and (F) (Student\'s t test; ^∗∗∗^p \< 0.001).\
(H) Reconstruction of representative control and shRNA^+^ cells in ectopic positions. The scale bar represents 50 μm.\
(I) Quantification of the number of control or shRNA^+^ cells that did not complete their migration, as in (H) (Student\'s t test; ^∗∗∗^p \< 0.001).\
(J) Quantification of the number of ectopic control or shRNA^+^ cells that displayed inverted orientation, as in (H). The data in (G)--(J) are mean percentages (±SEM) of the total number of ectopic cells (Student\'s t test; ^∗∗∗^p \< 0.001).\
(K) Quantification of the percentage of shRNA^+^ cells that did not complete migration and stopped in the upper or lower half of deep cortical layers. The pie histogram indicates the mean percentage of IN or UP cells observed in the two groups (Student's t test; ^∗∗∗^p \< 0.001).\
See [Figures S1--S4](#app2){ref-type="sec"}.](gr1){#fig1}

![The Expression of shRNA-Resistant SynIII Rescues the shRNA-Dependent Defects in Neuronal Migration and Orientation\
(A) Illustration showing the silent mutations in the shRNA-resistant variant of SynIII (rSynIII).\
(B) Western blot showing insensitivity of rSynIII versus sensitivity of WT SynIII to shRNA. The proteins were exogenously expressed in COS7 cells.\
(C) Confocal images of rat cortical coronal sections at E21 from animals transfected with shRNAscr (control), shRNA, or rSynIII/shRNA 0.5:1. The scale bar represents 100 μm.\
(D) Quantification of the number of PNs transfected with shRNAscr (control), rSynIII/shRNA, or shRNA and residing at the VZ/SVZ, IZ, and CP. The data are mean percentages (±SEM) of the total number of fluorescent cells. ANOVA on ranks; post hoc Dunn's test; ^∗∗∗^p \< 0.001.\
(E) Confocal images of rat cortical coronal sections at P7 from animals transfected with shRNAscr (control) or rSynIII/shRNA 0.5:1. The scale bar represents 100 μm.\
(F) Quantification of the number of shRNAscr, rSynIII/shRNA (0.5:1 ratio), or shRNA^+^ PNs that did not complete migration (one-way ANOVA; post hoc Tukey's test; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001).\
(G) Quantification of the number of ectopic PNs that displayed inverted orientation in shRNAscr, rSynIII/shRNA (0.5:1 ratio), and shRNA-treated cortices. The data are mean percentages (±SEM) of the total number of ectopic cells (one-way ANOVA; post hoc Tukey's test; ^∗∗∗^p \< 0.001).\
(H) Confocal images of rat cortical coronal sections at P7 from animals transfected with rSynIII/shRNA 0.5:1 or rSynIII/shRNA 1:1. The scale bar represents 50 μm.\
(I) Quantification of the distribution of CP cells in the three orientation classes shown in [Figure 1](#fig1){ref-type="fig"}D in animals transfected with shRNAscr, rSynIII/shRNA (0.5:1 ratio), rSynIII/shRNA (1:1 ratio), or shRNA. The data are mean percentages (±SEM) of the total number of fluorescent CP cells (one-way ANOVA; post hoc Tukey's test; ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001).\
See [Figure S6](#app2){ref-type="sec"}.](gr2){#fig2}

![SynIII KO Mice Exhibit a Cortical Migration Phenotype Similar to SynIII-KD Animals\
(A) Confocal images of coronal sections of rat somatosensory cortices at P7 after IUE at E17 with shRNA or SynI/shRNA. Arrowheads, example PNs that did not complete radial migration at P7 (black arrowheads, UP neurons; gray arrowheads, IN neurons). The scale bar represents 100 μm.\
(B) Quantification of the distribution of CP cells in the three distinct classes as in [Figure 1](#fig1){ref-type="fig"}D.\
(C) Quantification of the number of shRNA^+^ or SynI/shRNA^+^ cells that did not complete migration in experiments, as in (A).\
(D) Quantification of the number of ectopic shRNA^+^ or SynI/shRNA^+^ cells that displayed inverted orientation, as in (A). The data in (B)--(D) are mean percentages (±SEM) of the total number of ectopic cells.\
(E) Confocal images of coronal sections of somatosensory cortices from WT or SynIII KO C57BL/6 mice at P7, after IUE at E15.5 with tdTomato. The arrowheads point to example PNs that did not complete radial migration. The scale bar represents 100 μm.\
(F) Quantification of the distribution of cells in the three classes as in [Figure 1](#fig1){ref-type="fig"}D in WT or KO animals. The data are mean percentages (±SEM) of the total number of CP fluorescent cells (Student's t test: ^∗^p \< 0.05; ^∗∗^p \< 0.01).\
(G) Confocal images of coronal sections of somatosensory cortices from WT or SynIII KO C57BL/6 mice at P7, after IUE at E15.5 with tdTomato. The scale bar represents 50 μm.\
(H) High-magnification images of the boxed regions in (E). The scale bar represents 50 μm.\
See [Figure S5](#app2){ref-type="sec"}.](gr3){#fig3}

![Overexpression of SynIII Results in Ectopic Cells without Orientation Defects\
(A) Confocal images of coronal sections of the rat somatosensory cortex at E21 transfected with tdTomato (control) or SynIII. The scale bar represents 100 μm.\
(B) Quantification of the number of migrating PNs residing in the VZ/SVZ, IZ, or CP for control and SynIII-transfected animals. The data are mean percentages (±SEM) of the total number of fluorescent cells.\
(C) Confocal images of coronal sections of the rat somatosensory cortex at P7 transfected with tdTomato (control) or SynIII. The arrowheads point to PNs that did not complete radial migration. The scale bar represents 100 μm.\
(D) Representative reconstructions of control or SynIII-overexpressing PNs at CP. The scale bar represents 50 μm.\
(E) Quantification of the distribution of cells in the orientation classes shown in [Figure 1](#fig1){ref-type="fig"}D for control and SynIII-transfected cortices at the CP. The data are mean percentages (±SEM) of the total number of CP fluorescent cells.\
(F) Higher magnification of the boxed region in (C). The scale bar represents 25 μm.\
(G) Representative reconstructions of control or SynIII-overexpressing PNs in ectopic positions. The scale bar represents 50 μm.\
(H) Quantification of the number of control or SynIII-overexpressing PNs that did not complete migration. The data are mean percentages (±SEM) of the total number of fluorescent cells (Student's t test: ^∗∗^p \< 0.01).\
See [Figure S6](#app2){ref-type="sec"}.](gr4){#fig4}

![SynIII Interacts with CDK5 and Is Phosphorylated on Ser^404^\
(A) Representative western blot showing the temporal expression of CDK5 in comparison to actin in lysates of rat brain cortices.\
(B) Quantification of CDK5 expression in experiments as in (A).\
(C) Positive correlation between SynIII and CDK5 expression at the indicated ages. Dashed line: best fit (Pearson's correlation: ^∗∗^p \< 0.01). The data in (B) and (C) were normalized first to actin and then to the maximum detected optical density value; the values are expressed as means (±SEM; n = 3 animals/age).\
(D) Rat cortical neurons were lysed at 4 DIV and subjected to co-immunoprecipitation with anti-SynIII and anti-CDK5-specific antibodies and the appropriate control IgG (IP). INPUT, 10% of total lysate; SUPERNATANT, unbound fraction.\
(E) Confocal images of cultured neurons (3 DIV) stained for SynIII or p35. The scale bar represents 10 μm.\
(F) FLAG-WT SynIII and FLAG-S404A rSynIII were expressed in COS7 cells and immunoprecipitated with an anti-FLAG affinity gel. Protein expression and efficient immunoprecipitation were verified through western blot with an anti-SynIII antibody (INPUT, 5% total lysate; SUPERNATANT, unbound fraction).\
(G) The immunoprecipitated proteins (IP) were dephosphorylated and used as substrates for in vitro phosphorylation with active purified complex p35/CDK5 and radioactive \[γ-^32^P\]ATP. Radioactive phosphate incorporation in SynIII was detected through autoradiography of the SDS-PAGE gel.\
(H) Quantification of band intensity from the experiments shown in (D). The data are mean percentages (±SEM) of S404A-SynIII phosphorylation normalized to total phosphorylation of WT-SynIII (Student's t test: ^∗∗^p \< 0.01). The number of independent experiments is shown in parentheses.\
(I) Low-energy collision-induced dissociation (CID) tandem mass spectrum (MS/MS) showing phosphorylation at Ser404 of SynIII. The precursor mass measurement was collected in the Orbitrap to 1PPM of the theoretical mass. The MS/MS was collected in the linear ion trap. The site of phosphorylation was not ambiguous based on multiple diagnostic ions, particularly the y-12 and y-7 daughter ions. The high SEQUEST Xcorr value of 4.2 is given. In addition, diagnostic of Ser/Thr phosphorylation was the major peak in the spectrum corresponding to a neutral loss of phosphoric acid off the doubly charged precursor.\
(J) Western blot showing the temporal expression of SynIII and P-SynIII in comparison to actin in lysates of rat brain cortices.\
(K) Quantification of P-SynIII expression normalized to actin or SynIII, as in (A). The data were then normalized to the maximum detected optical density value; the values are expressed as means (±SEM; n = 3 animals/age).\
See [Figure S7](#app2){ref-type="sec"}.](gr5){#fig5}

![The Non-phosphorylatable SynIII Mutant at the CDK5 Phosphorylation Site Does Not Rescue shRNA-Induced Defects\
(A) Confocal images of cortical coronal sections of animals at E21 transfected with shRNAscr (control), S404A rSynIII, S404A rSynIII/shRNA, or shRNA. The scale bar represents 100 μm.\
(B) Quantification of the number of PNs residing in the VZ/SVZ, IZ, or CP in shRNAscr (control)-, S404A rSynIII-, S404A rSynIII/shRNA-, or shRNA-expressing cortices. The data are mean percentages (±SEM) of the total number of fluorescent cells in the section (one-way ANOVA; post hoc Holm-Sidak test: all conditions versus control ^∗∗∗^p \< 0.001).\
(C) Confocal images of cortical coronal sections at P7 from animals transfected with shRNAscr (control), S404A rSynIII, S404A rSynIII/shRNA (0.5:1 ratio), S404A rSynIII/shRNA (1:1 ratio), or shRNA. The scale bars represent 100 μm. Arrowheads, example PNs that did not complete radial migration (black, UP neurons; gray, IN neurons).\
(D) Quantification of the distribution of CP cells in the three orientation classes, as in [Figure 1](#fig1){ref-type="fig"}D (one-way ANOVA; post hoc Holm-Sidak test: ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001). The data are mean percentages (±SEM) of the total number of CP cells.\
(E) Quantification of the number of control, S404D rSynIII^+^, S404D rSynIII/shRNA^+^ (0.5:1 ratio), S404D rSynIII/shRNA^+^ (1:1 ratio), or shRNA^+^ cells that did not complete migration (one-way ANOVA; post hoc Holm-Sidak test: ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001).\
(F) Quantification of the percentage of inverted cells with respect to the total ectopic cells in the control, S404D rSynIII alone, S404D rSynIII/shRNA (0.5:1 ratio), and S404D rSynIII/shRNA (1:1 ratio) conditions (one-way ANOVA; post hoc Holm-Sidak test: ^∗^p \< 0.05; ^∗∗^p \< 0.01; ^∗∗∗^p \< 0.001).\
The data in (E) and (F) are mean percentages (±SEM) of the total number of ectopic cells. See [Figure S7](#app2){ref-type="sec"}.](gr6){#fig6}

![S404D rSynIII Expression Rescues the Phenotype Caused by KD of the Sema3A Receptor NP1\
(A) Representative western blot showing the phosphorylation of SynIII at Ser^404^ upon stimulation of 4-DIV primary cortical neurons with Sema3A.\
(B) Quantification of the phosphorylation of SynIII at Ser^404^ (optical density values are normalized to total SynIII expression) in experiments, as in (A). The data are mean percentages (±SEM) normalized to the control values (n = 6 samples per time point). The data are shown in a scatterplot that was fit with a logarithmic regression function (one-way ANOVA; post hoc Tukey's test: ^∗∗^p \< 0.01).\
(C) Representative western blot showing the temporal expression of NP1 in comparison to actin in lysates of rat brain cortices.\
(D) Quantification of NP1 expression in experiments as in (C).\
(E) Positive correlation between SynIII and NP1 expression at the indicated ages. Dashed line: best fit (Pearson's correlation: ^∗^p \< 0.05). The data in (D) and (E) were normalized first to actin and then to the maximum detected optical density value; the values are expressed as means (±SEM; n = 3 animals/age).\
(F) Confocal images of cultured neurons (DIV 3) stained for SynIII (green) or NP1 (red). The scale bar represents 10 μm.\
(G) Confocal images of cortical coronal sections at P7 from animals transfected with shRNAscr (control), NP1shRNA, or S404D rSynIII/NP1 shRNA. The scale bar represents 100 μm.\
(H) Quantification of the number of control, NP1 shRNA^+^, or S404D rSynIII/NP1 shRNA^+^ cells that did not complete migration (one-way ANOVA; post hoc Holm-Sidak test: ^∗∗∗^p \< 0.001).\
(I) Schematic model on the involvement of SynIII in the Sema3A/CDK5 pathway. Sema3A binds to the NP1/Plexin A2 complex, which activates Fyn kinase. Active Fyn phosphorylates CDK5 on Tyr^15^, promoting phosphorylation of SynIII on Ser^404^ by p35/CDK5. Phosphorylated SynIII may interact with its cytoskeletal partners and SVs to control neuronal migration and orientation.\
See [Figure S7](#app2){ref-type="sec"}.](gr7){#fig7}
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